McGill University researcher Dr. Bernard Belleau developed antiviral drug 3TC (Lamivudine), a critical component of Hepatitis B and HIV therapies
In 1989, McGill University researcher Dr. Bernard Belleau developed the antiviral drug 3TC (Lamivudine), which became a critical component of Hepatitis B and HIV therapies.
Tags:
Source: McGill University
Credit:
